Skip to main content
. 2022 May 13;81(7):545–552. doi: 10.1093/jnen/nlac034

TABLE 2.

Follow-Up Changes of Clinical Scales and Phosphorylated α-Synuclein Load in Curcumin-Supplemented and Untreated Parkinson Disease Patients

Supplemented p-Value Untreated p-Value
UPDRS off (score) 5 ± 5 0.0016* 11 ± 5 0.0001*
H&Y (score) 0.2 ± 0.4 0.0655 0.7 ± 0.4 0.0001*
COMPASS-31 (score) −0.5 ± 3 0.99 6 ± 4 0.11
NMSS (score) −2 ± 0.6 0.49 8 ± 7 0.0001*
Samples rate (%) −9 ± 8 0.52 18 ± 15 0.1
Adnexa rate (%) −5 ± 3 0.6 4 ± 8 0.93
L-dopa (mg/day) 0 150 ± 120 0.59

p-Values refer to comparisons from baseline (Table 1) and follow-up measurements. Data are reported as mean±SE.

*

Significant differences.